Autoinjectors & pens

Autoinjectors & pens
Product Description

Proven track record in managing parenteral customized solution and large scale industrialization projects of Autoinjectors and Pens with top pharmaceutical companies.

Our offer:

- disposable & reusable pen injectors
- Taylor-made autoinjectors & pens

NEMERA

  • FR
  • 2015
    On CPhI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Manufacturer/Innovator
Specifications
  • Supplied from
    France; United States

NEMERA

  • FR
  • 2015
    On CPhI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Manufacturer/Innovator

More Products from NEMERA

  • Sof'Airless: mini airless system for small dose dermal applications

    Product Sof'Airless: mini airless system for small dose dermal applications

    Nemera offers high performance airless delivery systems for dermal and transdermal solutions, lotions and creams.

    Nemera’s airless systems, pumps and valves are designed to handle a variety of formulations with different viscosities.



    Sof’Airless XS is a protective mini-airless system for small dose applications and sampling.


  • PUMPS SP27 / SP270+: quality and performance for ENT sprays

    Product PUMPS SP27 / SP270+: quality and performance for ENT sprays

    Nemera offers an extensive range of metered pumps and valves, compatible with a wide choice of actuators in different shapes and fitments for nasal, buccal and auricular delivery.
    Here our different pumps:
    SP27 - SP 37: Quality systems for unregulated markets

    SP270+ - SP370+: Quality and performance for ENT sprays in regulated markets
  • Safe’n’Sound®: our passive safety device – Robust and ergonomic design for user safety

    Product Safe’n’Sound®: our passive safety device – Robust and ergonomic design for user safety

    Safe’n’Sound®: the safety device solution for small molecules and biologics
    Nemera leverages decades of manufacturing and development experience in parenteral complex devices moulding and assembly such as safety devices, pens, autoinjectors and implanters.

    Nemera’s Safe’n’Sound®, a fully passive safety device for prefilled syringes to aid in the protection of healthcare professionals, patients who self-inject doctor prescribed medications, and individuals that assist self-injecting patients, from accidental needle sticks.
  • Novelia®: Nemera’s preservative-free multidose eyedropper

    Product Novelia®: Nemera’s preservative-free multidose eyedropper

    Novelia®: Nemera’s preservative-free multidose eyedropper, is used across 4 continents
    Preservatives have been shown to be harmful to the eye and can lead patients to discontinue or skip treatment to avoid irritation and discomfort.
    The new preservative-free multidose ophthalmic packaging Novelia® avoids the need for preservatives in the drug by preventing contamination of unpreserved formulations.
    Novelia® has been well accepted by patients in over 15 countries worldwide, including the US, European, Latin American and Asian countries. It is used as for packaging drug products as well as medical devices.
  • DPIs / PMDIs : expert in development & manufacturing of respiratory drug delivery devices

    Product DPIs / PMDIs : expert in development & manufacturing of respiratory drug delivery devices

    Nemera has a recognized expertise in the development and manufacturing of respiratory drug delivery devices, such as Dry Powder Inhalers (DPIs), pressurized Metered Dose Inhalers (pMDIs) and dose counters.

    More than ten million asthmatics rely everyday on devices manufactured by Nemera.
  • Sof'Bag®: airless pouch system for dermal & transdermal applications

    Product Sof'Bag®: airless pouch system for dermal & transdermal applications

    Nemera offers high performance airless delivery systems for dermal and transdermal solutions, lotions and creams.

    Nemera’s airless systems, pumps and valves are designed to handle a variety of formulations with different viscosities.

    Sof’Bag® is a high-performing airless pouch system for dermal and transdermal applications.

  • Implanters

    Product Implanters

    Implants are fragile and insertion into the body requires caution. Nemera developed a portfolio of devices to deliver implants with integrated needlestick protection.

    There is two types of implanters:

    - Safety depot syringe with telescopic plunger rod
    - Safety retro injector for soft implants
  • RetroNose®: the pMDI concept device targeting nasal drug delivery through oral administration

    Product RetroNose®: the pMDI concept device targeting nasal drug delivery through oral administration

    With RetroNose®, enhance therapeutic efficacy of your nasal drug with a better deposition
  • Safe'n'Spray™: the smart electronic concept device with locking features

    Product Safe'n'Spray™: the smart electronic concept device with locking features

    Safe'n'Spray™: the integrated device with reusable electronic locking unit and fingerprint identification, to monitor drug delivered and prevent overdosing. Normal 0 21 false false false FR X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Tableau Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-fareast-language:EN-US;}
  • Smart wearable to improve patients’ life.

    Product Smart wearable to improve patients’ life.

    Symbioze smart wearable platform is an innovative, large-volume on-body injector to foster patient’s adherence. It offers a great combination between design robustness, ease of use, connectivity, and sustainability, for a seamless and enhanced injection experience.

NEMERA resources

  • News Nemera: Stronger than ever

    More modern, our new brand identity truly embodies who we are, how we partner with our customers and ultimately the value we bring to millions of patients across the world through our drug delivery device solutions.
  • Video Innovation in Connectivity Roundtable pt.1

    The Innovation in Connectivity Roundtable originally aired as part of Pharmapack Europe 2021 Part 1 of this session includes three presentations: Patient Journey Driven Considerations for Integrating Digital Health for Combination Products The importance of utilizing applied ethnography and other primary research methods to understand the patient journey as the foundation for integrating digital health into a device/combination product development initiative. Considering patient needs in the context of a larger ecosystem including providers, payers, and regulators to develop a robust plan with respect to connectivity and digital health. Examples of how this understanding is applied across the combination product development journey through organic development, utilization of platform devices, or as a lifecycle management enchantments while optimizing the user experience resulting in safe, effective, and differentiated combination products. Mark Tunkel, Global Category Director for Insight Innovation, Nemera Electronic Product Information: A Case Study on Medicine Labelling for the Visually Impaired The Electronic Product Information Initiative for Medicines (ePI) aim to ease the accessibility of product information to everyone, including visually impaired patients. The GS1 Digital Link aim to provide a single barcode for identification, brand protection, and access to product information for patients. Our lecture will illustrate how the existing Datamatrix on packaging could be leveraged, today, by everyone, including visually impaired users, to access a tailored and relevant information. Laurent Tonnelier, CEO, mobiLead - xTag Lise Wagner, Accessibility Specialist and User Expert, OKEENEA Traceability of Medicines: from Finished Product to Unit Dose Delivery Challenges for B2B Supply Chain stakeholders Regulations: a global overview What about B2C Nathalie Wardé, CEO & Founder, D4P pharma Join the above speakers and moderator Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG for the live panel discussion that followed in the Innovation in Connectivity Roundtable pt. 2
  • News Pharmapack Europe 2021 announces Awards winners!

    Awards showcased a wide range of industry-changing innovations in packaging and drug delivery, with sustainability emerging as a key metric across all categories
  • Video Innovation in Connectivity Roundtable pt. 2

    The second part of the Innovation in Connectivity Roundtable brings together presenters from Nemera, D4P Pharma and xTag for a group discussion and live Q&A (45-minutes). Moderated by Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG Participants: Mark Tunkel, Global Category Director for Insight Innovation, Nemera Laurent Tonnelier, CEO, mobiLead – xTag Lise Wagner, Accessibility Specialist and User Expert, OKEENEA Nathalie Wardé, CEO & Founder, D4P pharma This webinar originally aired as part of Pharmapack 2021
  • News Pharmapack 2021: Increasing connectivity is the key to patient centricity and simplified access to product information

    During the live Innovation in Connectivity Roundtable at the Pharmapack 2021 online conference, experts discussed how the latest innovations in digital technology are shaping industry ambitions to put the patient journey at the heart of its drug device and delivery solutions by simplifying product information via increased connectivity.
  • Video Welcome to the Digital Health & Connectivity & Patient-Centricity Track

    This webinar will address: Key market trends in digital health and how they have accelerated in the past years Nemera’s vision of digital health and the implications on the whole drug/device development ecosystem – how connectivity is creating incredible opportunities for the industry but also raises some challenges: link to conferences in the track How does Nemera play in this landscape: presentation of the company, our capabilities and some examples of our connected devices. Webinar originally aired as part of Pharmapack Europe 2021
  • News RETRONOSE: IMPROVING NASAL DELIVERY THROUGH NEW AND IMPROVED DEVICE

    RetroNose is a completely new drug delivery concept to dispense drug formulation to the nasal cavity. The principle of this concept is to deliver a spray through the oral cavity to deposit the drug in the nasal cavity from rear to front. To avoid aerosol penetration in the lung and to ensure deposition efficacy, the aerosol drug is automatically delivered during the nasal expiratory phase.
  • Video Nemera: We Put Patients First

    As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint to market of their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission.
    For more information, visit www.nemera.net
  • Video NEMERA CEO SHARES 2021 AMBITION

    Our CEO, Marc Hämel shares the lessons we learned from last year, extends his wishes, gratitude to the Nemera family and walks us through the top company goals that will shape and drive our story in 2021!
  • Video Nemera at CPhI Worldwide 2019 - Bernhard Rohn and Mark Tunkel

    Our VP strategy and marketing and our director of business development, Insight Innovation Center are presenting Nemera and its portfolio. They are giving more details about Insight Innovation Center.
  • Video Nemera at CPhI Worldwide 2018

    Nemera, Juan Sarmien, Sales Director for North America at Nemera, speaks with CPhI TV at CPhI Worldwide in Madrid.
  • Video Nemera: Sronger Than Ever

    Our proven experience in the complementary activities surrounding drug delivery device and combination product development, alongside our strong know-how in our industry ecosystem, puts us in an optimal place to support our customers as partners through every step in their journey. By keeping the patient top of mind, we create success on all fronts. We aim to improve patients’ outcomes and build customer success. In order to do that, we have three key pillars that form the base of our organizational identity: • Patients first. Always. • Partnering in drug delivery devices. Holistically. • Going the extra mile. Together. Our new logo and a new brand style convey this message to customers, applicants, shareholders, and other stakeholders, with a fresh, friendly, and moving-forward look and feel.

Recommended products